(VIANEWS) - Gray Communications Systems (GTN), Amphastar Pharmaceuticals (AMPH), Baxter International (BAX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Gray Communications Systems (GTN)
59.3% sales growth and 7.01% return on equity
Gray Television, Inc., an American television broadcasting company, operates and owns television stations in America. It also broadcasts digital secondary channels that are affiliated with ABC, CBS and FOX. The Network, and local weather channels in different markets. It is involved in video programming, digital marketing and businesses such as Raycom Sports and Tupelo-Raycom; production of PowerNation content and programs. It owned or operated 93 TV markets as of February 21st 2020. Gray Communications Systems, Inc. was the company's former name. Gray Television, Inc. took over its operations in August 2002. Gray Television, Inc. was established in Atlanta, Georgia in 1897.
Gray Communications Systems's sales growth this year is anticipated to be 57.2% and a negative 11.2% for next year.
Year-on-year quarterly revenue growth grew by 58.7%, now sitting on 3.02B for the twelve trailing months.
Volume
Today's last reported volume for Gray Communications Systems is 365049 which is 52.46% below its average volume of 767953.
Gray Communications Systems's sales growth is a negative 0% for the ongoing quarter and 59.3% for the next. The company's growth estimates for the ongoing quarter and the next is 540.6% and 1552.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.01%.
Volatility
Gray Communications Systems's last day, last week, and last month's current intraday variation average was 3.52%, 1.44%, and 1.52%, respectively.
Gray Communications Systems's highest amplitude of average volatility was 3.39% (day), 2.65% (last week), and 2.58% (last month), respectively.
Gray Communications Systems's Stock Yearly Top and Bottom Value
Gray Communications Systems's stock is valued at $19.13 at 11:22 EST, way below its 52-week high of $25.24 and way above its 52-week low of $16.13.
Gray Communications Systems's Moving Average
Gray Communications Systems's worth is higher than its 50-day moving average of $18.67 and under its 200-day moving average of $20.22.2. Amphastar Pharmaceuticals (AMPH)
15.4% sales growth and 17.97% return on equity
Amphastar Pharmaceuticals, Inc., is a specialty pharmaceutical firm that develops, manufactures, market and sells intranasal, injectable, and inhalation products. It operates in France, China, the United States, and France. Two segments of the company are Finished Pharmaceutical Products (API) and Other Products (FPP). The company offers Primatene Mist (an over-the-counter epinephrine injection product to temporarily relieve mild symptoms of intermittent asthma); Enoxaparin (a low-molecular-weight heparin that prevents and treats deep vein thrombosis); Naloxone (for opioid overdose); Glucagon emergency kit; Cortrosyn (a lyophilized powder used in diagnosis of patients suffering from adrenocortical impairment). Amphadase is a bovine-sourced, injectable hyaluronidase that can absorb and disperse other drugs. Epinephrine injections are used to treat allergic reactions. Lidocaine jelly for anesthesia for urological procedures. The topical solutions for many procedures include lidocaine, lidocaine, and phytonadione. There are also emergency syringes for hospital use. Morphine can be used with patient controlled pain pumps. Lorazepam for medical and for injections. It also offers Procainamide to relieve documented arrhythmias, neostigmine, a methylsulfate injection, to treat myasthenia Gravis, and reverse the effects muscle relaxants, and medroxyprogesterone topical solution for various procedures. The company serves healthcare facilities, alternative care sites, clinics and doctor's offices. Rancho Cucamonga is the headquarters of this company, which was established in 1996.
Amphastar Pharmaceuticals's sales growth this year is anticipated to be 15.6% and 8.7% for next year.
Year-on-year quarterly revenue growth grew by 16.8%, now sitting on 455.12M for the twelve trailing months.
Volume
Today's last reported volume for Amphastar Pharmaceuticals is 208800 which is 58.18% below its average volume of 499314.
Amphastar Pharmaceuticals's sales growth is a negative 0% for the present quarter and 15.4% for the next. The company's growth estimates for the present quarter and the next is 71.4% and negative -10.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.97%.
Volatility
Amphastar Pharmaceuticals's last day, last week, and last month's current intraday variation average was 1.84%, 1.71%, and 2.20%, respectively.
Amphastar Pharmaceuticals's highest amplitude of average volatility was 2.99% (day), 3.28% (last week), and 4.62% (last month), respectively.
Amphastar Pharmaceuticals's Stock Yearly Top and Bottom Value
Amphastar Pharmaceuticals's stock is valued at $31.01 at 11:22 EST, way under its 52-week high of $44.46 and way above its 52-week low of $17.56.
Amphastar Pharmaceuticals's Moving Average
Amphastar Pharmaceuticals's value is way under its 50-day moving average of $34.51 and above its 200-day moving average of $30.70.3. Baxter International (BAX)
13.6% sales growth and 11.72% return on equity
Baxter International Inc. and its subsidiaries develop and provide a range of healthcare products around the world. It offers intravenous dialysis, hemodialysis and extra dialysis services. The company also offers connected care services, which include devices, software and communications; integrated patient monitoring, diagnostic technologies and technologies for diagnosing, treating, and managing various illnesses and diseases. These technologies include respiratory therapy, cardiac screening and vision screening; and surgical video technologies. It can provide tables, lighting, pendants and precision positioning devices as well as other accessories. The company also offers contract services to several pharmaceutical and biopharmaceutical businesses. The company's products can be found in hospitals, dialysis centers and nursing homes as well as rehabilitation centers and doctors offices. It also serves patients at home with physician supervision. It sells products via direct sales, independent distributors and drug wholesalers. Celerity Pharmaceutical, LLC has signed an agreement to create oncolytic and acute care generic injectable premixes. Baxter International Inc., which was founded in 1931, is located in Deerfield Illinois.
Baxter International's sales growth this year is expected to be 20.7% and 3.7% for next year.
Year-on-year quarterly revenue growth grew by 20.9%, now sitting on 14.19B for the twelve trailing months.
Volume
Today's last reported volume for Baxter International is 369446 which is 88.42% below its average volume of 3190490.
Baxter International's sales growth for the next quarter is 13.6%. The company's growth estimates for the present quarter and the next is a negative 5.9% and 6.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.72%.
Volatility
Baxter International's last day, last week, and last month's current intraday variation average was 0.42%, 2.43%, and 1.62%, respectively.
Baxter International's highest amplitude of average volatility was 1.26% (day), 3.38% (last week), and 2.57% (last month), respectively.
Baxter International's Stock Yearly Top and Bottom Value
Baxter International's stock is valued at $58.86 at 11:22 EST, way under its 52-week high of $89.70 and higher than its 52-week low of $54.45.
Baxter International's Moving Average
Baxter International's value is below its 50-day moving average of $61.31 and way below its 200-day moving average of $74.46.4. Owens Corning (OC)
9.6% sales growth and 26.01% return on equity
Owens Corning and its subsidiaries produce and sell glass fiber reinforcements, as well as other materials, for composites. They also supply residential, commercial and industrial building materials around the world. The company operates three divisions: Insulation, Composites and Roofing. Composites manufactures, fabricates and markets glass reinforcements as fiber. It also manufactures and distributes specialty products such as fabrics and non-wovens. These products can be found in pipes, roof shingles, sport goods, consumer electronics and telecommunications cables. They also make and sell industrial containers and glass fiber products for wind-energy and building construction. Fiberglass insulation is manufactured and sold in residential, commercial and industrial markets. It also manufactures flexible duct media and glass fiber pipe insulation. Cellular glass insulation can be used for above- or below-grade construction. The segment is mainly sold to insulation contractors, home centers and lumberyards. It also sells products under the FIBERGLAS Insulation, FOAMGLAS and Paroc brand names. The segment Roofing manufactures and markets residential roofing shingles and oxidized asphalt material, roofing components for residential and commercial constructions, specialty applications and synthetic packaging materials. The segment's products are sold through retailers, distributors, lumberyards and contractors. It also sells to roofers for built up roofing asphalt systems as well to companies in the automotive, chemical and rubber industries. Owens Corning, a company that was established in 1938, is located in Toledo Ohio.
Owens Corning's sales growth this year is expected to be 15.8% and a negative 1% for next year.
Year-on-year quarterly revenue growth grew by 16.2%, now sitting on 9.29B for the twelve trailing months.
Volume
Today's last reported volume for Owens Corning is 792444 which is 21.85% below its average volume of 1014050.
Owens Corning's sales growth for the next quarter is 9.6%. The company's growth estimates for the present quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.01%.
Volatility
Owens Corning's last day, last week, and last month's current intraday variation average was 5.04%, 2.34%, and 1.75%, respectively.
Owens Corning's highest amplitude of average volatility was 5.24% (day), 2.91% (last week), and 2.56% (last month), respectively.
Owens Corning's Stock Yearly Top and Bottom Value
Owens Corning's stock is valued at $85.33 at 11:22 EST, way below its 52-week high of $101.12 and way higher than its 52-week low of $72.97.
Owens Corning's Moving Average
Owens Corning's worth is higher than its 50-day moving average of $83.56 and under its 200-day moving average of $89.23.5. International Paper Company (IP)
9.4% sales growth and 16.3% return on equity
International Paper Company is a leading packaging company in the Americas, including the United States, Middle East, Europe and Africa. The company operates in two main segments, Industrial Packaging and Global Cellulose Fibers. Industrial Packaging produces containerboards. This includes linerboard, medium and whitetop as well as recycled linerboard and recycled medium. Global Cellulose Fibers provides fluff and market pulps for absorbent products such as diapers, feminine care and adult incontinence products. The company sells directly to converters and end users, but also through paper distributors, agents, resellers and representatives. It was established in Memphis, Tennessee in 1898.
International Paper Company's sales growth this year is anticipated to be 10.9% and 1% for next year.
Year-on-year quarterly revenue growth grew by 13%, now sitting on 20.63B for the twelve trailing months.
Volume
Today's last reported volume for International Paper Company is 1783740 which is 36.22% below its average volume of 2797040.
International Paper Company's sales growth for the next quarter is 9.4%. The company's growth estimates for the ongoing quarter and the next is 5.9% and 82.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.3%.
Volatility
International Paper Company's last day, last week, and last month's current intraday variation average was 1.08%, 0.82%, and 1.10%, respectively.
International Paper Company's highest amplitude of average volatility was 2.01% (day), 1.96% (last week), and 2.19% (last month), respectively.
International Paper Company's Stock Yearly Top and Bottom Value
International Paper Company's stock is valued at $40.91 at 11:22 EST, way under its 52-week high of $56.57 and above its 52-week low of $40.13.